PLEASE NOTE: THE DECISIONS PUBLISHED ON THIS WEB SITE ARE NOT AN ALL-INCLUSIVE LISTING OF ALL CASES INVOLVING EMORD AND ASSOCIATES AS COUNSEL. RESULTS DEPEND UPON A VARIETY OF FACTORS UNIQUE TO EACH CASE. THE RESULTS PUBLISHED HERE DO NOT GUARANTEE OR PREDICT A SIMILAR RESULT IN ANY FUTURE CASE UNDERTAKEN BY THE FIRM.
The following includes a representative sample of recent decisions, pleadings, and presentations.
LEGAL DECISIONS:
- Albion International, Inc. v. AIC, et al, Memorandum Decision re Laches
- Alliance for Natural Health US v. Sebelius, et al.
- In re ECM Biofilms, Inc. FTC Docket No. 9358 AL Initial Decision Jan 28, 2015)
- Novelty Distributors, Inc.: Revocation of Registration (DEA)
- Novelty v. DEA
- Nutraceutical Corp. v. Von Eschenbach
- Nutraceutical Corp. v. Crawford
- Pearson v. Shalala
- Pearson v. Shalala, en banc
- Pearson v. Shalala II
- Pearson v. Thompson
- U.S. Citizens Association, et al. v. Kathleen Sebelius, et al.
- Whitaker v. Thompson I
- Whitaker v. Thompson II
- Whitaker v. Thompson III
COMPLAINTS:
- FDA Antioxidant Qualified Health Claim Complaint
- FDA CGMP Complaint
- FDA Selenium Qualified Health Claim Complaint
- Saw Palmetto / BPH Complaint
- B-Vitamin / Vascular Disease and E-Vitamin / Heart Disease Complaint
- Medicinal Marijuana Complaint
- Folic Acid Complaint Antioxidant Complaint
BRIEFS:
- Opposition to Motion to Dismiss in Health Reform Case
- Novelty Petition for Writ of Certiorari
- Antioxidant Qualified Health Claims / Memorandum in Support of Motion for Summary Judgment
- Nutraceutical Corp. v. Von Eschenbach Appellees’ Petition for Rehearing
- Saw Palmetto / Memorandum in Support of Motion for Summary Judgment
- Saw Palmetto/BPH Opposition To Motion To Dismiss
- Medicinal Marijuana Application for Preliminary Injunction
- Pearson Remand Application for Preliminary Injunction
- Pearson Remand Memorandum in Support of Application for Preliminary Injunction
- Pearson Remand Memorandum in Support of Motion to Supplement
- Pearson Remand Memorandum in Support of Reply to Opposition
- Folic Acid Motion for Preliminary Injunction and Memo in Support
- Folic Acid / Reply to Opposition to Motion for Summary Judgment
- Folic Acid / Reply to Opposition to Application for Preliminary Judgment
- Folic Acid / Opposition to Motion to Dismiss
- Folic Acid / Opposition to Petition for Reconsideration
- Saw Palmetto / Reply to Opposition to Motion for Summary Judgment
- Memorandum in Support of Application for Preliminary Injunction in the Antioxidant Case
COMMENTS/PETITIONS:
- ANH Comments in re Medicare Revisions to promote Program Efficiency (Apr. 2013)
- CBNS Comments in re Medicare Revisions to promote Program Efficiency (Apr. 2013)
- AbleChild.org Appeal to Connecticut Freedom of Information Commission (Apr. 2013)
- EDA New Dietary Ingredient (NDI) Comments on FDA Guidance Document (Dec. 2011)
- EDA New Dietary Ingredient (NDI) Comments on Economic Burden
- FDA grants qualified claims for calcium and colon/rectal cancer and polyps
- FDA grants qualified claims for calcium and hypertension
- Chromium Picolinate Petition Decision
- The Coronary Heart Disease Risk Reducing Effects of N-3 Fatty Acids
- Connor’s Scientific References
- Final Comments on Proposed CGMPs
- Comments on Qualified Health Claims
- Comments on FDA’s Task Force on Consumer Health Information for Better Nutrition
- FTC First Amendment Petition
- Ephedra Comments
- First Amendment Reply Comments
- First Amendment Comments
- Saw Palmetto / BPH Health Claim Petition
- B-Vitamin / Vascular Disease Health Claim Petition
- E-Vitamin / Heart Disease Health Claim Petition
- Comments on Proposed GMPs for Dietary Supplements
- Comments on Proposed Ephedra Regulations
- Petition for Rulemaking Calling on FTC to Define Competent and Reliable Scientific Evidence
- Comments to HCFA on Privacy Regulations
- Comments on FDA’s Significant Scientific Agreement Standard
- Structure/Function Claims Proposed Rule
CONGRESSIONAL TESTIMONY:
FDA TESTIMONY:
COURT TRANSCRIPTS & ORAL ARGUMENT:
- Feb. 8, 2019 Oral Argument, Natural Immunogenics Corp. v. Ferrell (9th Cir. No. 17-55661) (Attorney Arhangelsky)
- Dec. 3, 2018 Oral Argument, Youngevity Int’l Corp. v. Andreoli (9th Cir. No. 18-55031) (Attorney Emord)
- April 10, 2000, Pearson v. Shalala Preliminary Injunction Hearing
- October 28, 2002, Whitaker v. Thompson Motions Hearing
SPEECHES:
- The Destruction of Solo and Small Group Medical Practices by Medicare (Heritage Foundation)
- Speech on FDA Violation of First Amendment (FDLI)
CONTRIBUTIONS:
Individuals and entities interested in making a financial contribution to any of our Litigation Funds should contact:
Jonathan Emord. Emord & Assiciates, P.C.,
11808 Wolf Run Lane
Clifton, VA 20124
(202-466-6937) for additional information.